UNITED STATES PERIPHERAL ARTERY DISEASE MARKET FORECAST 2021-2026

The United States peripheral artery disease market is evaluated to develop with a CAGR of 11.23% during the forecasting period. Factors such as technological advancements in peripheral artery disease devices, the well-established healthcare sector, the increasing incidence of diabetes and obesity, and the surging prevalence of peripheral artery disease are projected to drive the country’s market growth. While the base year considered for the market study is 2020, the forecast years are from 2021 to 2026.

united-states-peripheral-artery-disease-market

Peripheral artery disease (PAD) entails the disorder of blood vessels located on the exterior of the heart and brain. The condition occurs when plaque accumulates in arteries carrying blood to the organs, head, and limbs. Plaque constitutes fat, calcium, cholesterol, and fibrous tissue, in addition to other substances. Although PAD typically affects arteries in the legs, it can also impact arteries that transport blood from the heart to the head, kidneys, arms, and stomach.

The rising patient pool in the United States is among the key drivers fueling the country’s peripheral artery disease market. Moreover, the development of peripheral artery disease is also linked to diabetes and obesity. The journal published by the National Center for Biotechnology Information (NCBI), as well as the research conducted by the American Society of Clinical Oncology in 2015, concluded that smoking and obesity significantly contributed to the surging cases of peripheral diseases in the United States. Hence, these factors are set to fuel the country’s market growth over the forecasted period.

Boston Scientific Corporation, headquartered in the United States, is a leading manufacturer, developer, and marketer of medical devices used across interventional medical specialties. Its interventional cardiology business unit manufactures products used to treat and diagnose coronary artery disease, in addition to other cardiovascular disorders. The company is operational in Europe, the Americas, the Middle East & Africa, and the Asia-Pacific.

TABLE OF CONTENTS
  1. RESEARCH SCOPE & METHODOLOGY
    1. STUDY OBJECTIVES
    2. SCOPE OF STUDY
    3. METHODOLOGY
    4. ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    1. MARKET SIZE & ESTIMATES
    2. COUNTRY SNAPSHOT
    3. COUNTRY ANALYSIS
    4. KEY GROWTH ENABLERS
    5. KEY CHALLENGES
  3. KEY ANALYTICS
    1. IMPACT OF COVID-19 ON PERIPHERAL ARTERY DISEASE MARKET
    2. KEY INVESTMENT INSIGHTS
    3. PORTER’S FIVE FORCES ANALYSIS
      1. BUYERS POWER
      2. SUPPLIERS POWER
      3. SUBSTITUTION
      4. NEW ENTRANTS
      5. INDUSTRY RIVALRY
    4. OPPORTUNITY MATRIX
    5. VENDOR LANDSCAPE
  4. MARKET BY DEVICES
    1. PERIPHERAL STENTS
      1. SELF-EXPANDABLE
      2. BALLOON-EXPANDABLE
      3. COVERED
      4. DRUG-ELUTING STENTS
    2. PERIPHERAL ANGIOPLASTY BALLOONS
      1. OLD/NORMAL BALLOONS
      2. CUTTING & SCORING BALLOONS
      3. DRUG-COATED BALLOONS
    3. PLAQUE MODIFICATION DEVICES
      1. THROMBECTOMY DEVICES
        1. MECHANICAL
        2. ASPIRATION
        3. RHEOLYTIC
      2. ATHERECTOMY DEVICES
    4. INFERIOR VENA CAVA (IVC) FILTERS
      1. PERMANENT FILTERS
      2. RETRIEVABLE FILTERS
    5. HEMODYNAMIC FLOW ALTERATION DEVICES
      1. EMBOLIC PROTECTION DEVICES
      2. CHRONIC TOTAL OCCLUSION DEVICES
    6. PERIPHERAL CATHETERS
      1. ANGIOGRAPHY CATHETERS
      2. GUIDING CATHETERS
    7. PERIPHERAL ACCESSORIES
      1. PERIPHERAL VASCULAR CLOSURE DEVICES
      2. GUIDEWIRES
      3. BALLOON INFLATION DEVICES
      4. INTRODUCER SHEATHS
  5. COMPETITIVE LANDSCAPE
    1. KEY STRATEGIC DEVELOPMENTS
      1. MERGERS & ACQUISITIONS
      2. PRODUCT LAUNCHES & DEVELOPMENTS
      3. PARTNERSHIPS & AGREEMENTS
      4. BUSINESS EXPANSIONS, ANNOUNCEMENTS & DIVESTITURES
    2. COMPANY PROFILES
      1. ABBOTT LABORATORIES
      2. ANGIODYNAMICS INC
      3. BECTON, DICKINSON AND COMPANY
      4. BOSTON SCIENTIFIC CORPORATION
      5. CARDINAL HEALTH INC
      6. MEDTRONIC PLC
LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - PERIPHERAL ARTERY DISEASE

TABLE 2: UNITED STATES PERIPHERAL ARTERY DISEASE MARKET, BY DEVICES, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 3: UNITED STATES PERIPHERAL ARTERY DISEASE MARKET, BY DEVICES, FORECAST YEARS, 2021-2026 (IN $ MILLION)

TABLE 4: UNITED STATES PERIPHERAL STENTS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 5: UNITED STATES PERIPHERAL STENTS MARKET, BY TYPE, FORECAST YEARS, 2021-2026 (IN $ MILLION)

TABLE 6: UNITED STATES PERIPHERAL ANGIOPLASTY BALLOONS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 7: UNITED STATES PERIPHERAL ANGIOPLASTY BALLOONS MARKET, BY TYPE, FORECAST YEARS, 2021-2026 (IN $ MILLION)

TABLE 8: UNITED STATES PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 9: UNITED STATES PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, FORECAST YEARS, 2021-2026 (IN $ MILLION)

TABLE 10: UNITED STATES INFERIOR VENA CAVA (IVC) FILTERS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 11: UNITED STATES INFERIOR VENA CAVA (IVC) FILTERS MARKET, BY TYPE, FORECAST YEARS, 2021-2026 (IN $ MILLION)

TABLE 12: UNITED STATES HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 13: UNITED STATES HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, FORECAST YEARS, 2021-2026 (IN $ MILLION)

TABLE 14: UNITED STATES PERIPHERAL CATHETERS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 15: UNITED STATES PERIPHERAL CATHETERS MARKET, BY TYPE, FORECAST YEARS, 2021-2026 (IN $ MILLION)

TABLE 16: UNITED STATES PERIPHERAL ACCESSORIES MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 17: UNITED STATES PERIPHERAL ACCESSORIES MARKET, BY TYPE, FORECAST YEARS, 2021-2026 (IN $ MILLION)

TABLE 18: LIST OF MERGERS & ACQUISITIONS

TABLE 19: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 20: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 21: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES

LIST OF FIGURES

FIGURE 1: PORTER’S FIVE FORCES ANALYSIS

FIGURE 2: OPPORTUNITY MATRIX

FIGURE 3: VENDOR LANDSCAPE

FIGURE 4: KEY INVESTMENT INSIGHTS

FIGURE 5: UNITED STATES PERIPHERAL ARTERY DISEASE MARKET, BY DEVICES, IN 2020

FIGURE 6: UNITED STATES PERIPHERAL ARTERY DISEASE MARKET, BY PERIPHERAL STENTS, 2021-2026 (IN $ MILLION)

FIGURE 7: UNITED STATES PERIPHERAL STENTS MARKET, BY SELF-EXPANDABLE, 2021-2026 (IN $ MILLION)

FIGURE 8: UNITED STATES PERIPHERAL STENTS MARKET, BY BALLOON-EXPANDABLE, 2021-2026 (IN $ MILLION)

FIGURE 9: UNITED STATES PERIPHERAL STENTS MARKET, BY COVERED, 2021-2026 (IN $ MILLION)

FIGURE 10: UNITED STATES PERIPHERAL STENTS MARKET, BY DRUG-ELUTING STENTS, 2021-2026 (IN $ MILLION)

FIGURE 11: UNITED STATES PERIPHERAL ARTERY DISEASE MARKET, BY PERIPHERAL ANGIOPLASTY BALLOONS, 2021-2026 (IN $ MILLION)

FIGURE 12: UNITED STATES PERIPHERAL ANGIOPLASTY BALLOONS MARKET, BY OLD/NORMAL BALLOONS, 2021-2026 (IN $ MILLION)

FIGURE 13: UNITED STATES PERIPHERAL ANGIOPLASTY BALLOONS MARKET, BY CUTTING & SCORING BALLOONS, 2021-2026 (IN $ MILLION)

FIGURE 14: UNITED STATES PERIPHERAL ANGIOPLASTY BALLOONS MARKET, BY DRUG-COATED BALLOONS, 2021-2026 (IN $ MILLION)

FIGURE 15: UNITED STATES PERIPHERAL ARTERY DISEASE MARKET, BY PLAQUE MODIFICATION DEVICES, 2021-2026 (IN $ MILLION)

FIGURE 16: UNITED STATES PLAQUE MODIFICATION DEVICES MARKET, BY THROMBECTOMY DEVICES, 2021-2026 (IN $ MILLION)

FIGURE 17: UNITED STATES THROMBECTOMY DEVICES MARKET, BY MECHANICAL, 2021-2026 (IN $ MILLION)

FIGURE 18: UNITED STATES THROMBECTOMY DEVICES MARKET, BY ASPIRATION, 2021-2026 (IN $ MILLION)

FIGURE 19: UNITED STATES THROMBECTOMY DEVICES MARKET, BY RHEOLYTIC, 2021-2026 (IN $ MILLION)

FIGURE 20: UNITED STATES PLAQUE MODIFICATION DEVICES MARKET, BY ATHERECTOMY DEVICES, 2021-2026 (IN $ MILLION)

FIGURE 21: UNITED STATES PERIPHERAL ARTERY DISEASE MARKET, BY INFERIOR VENA CAVA (IVC) FILTERS, 2021-2026 (IN $ MILLION)

FIGURE 22: UNITED STATES INFERIOR VENA CAVA (IVC) FILTERS MARKET, BY PERMANENT FILTERS, 2021-2026 (IN $ MILLION)

FIGURE 23: UNITED STATES INFERIOR VENA CAVA (IVC) FILTERS MARKET, BY RETRIEVABLE FILTERS, 2021-2026 (IN $ MILLION)

FIGURE 24: UNITED STATES PERIPHERAL ARTERY DISEASE MARKET, BY HEMODYNAMIC FLOW ALTERATION DEVICES, 2021-2026 (IN $ MILLION)

FIGURE 25: UNITED STATES HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY EMBOLIC PROTECTION DEVICES, 2021-2026 (IN $ MILLION)

FIGURE 26: UNITED STATES HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY CHRONIC TOTAL OCCLUSION DEVICES, 2021-2026 (IN $ MILLION)

FIGURE 27: UNITED STATES PERIPHERAL ARTERY DISEASE MARKET, BY PERIPHERAL CATHETERS, 2021-2026 (IN $ MILLION)

FIGURE 28: UNITED STATES PERIPHERAL CATHETERS MARKET, BY ANGIOGRAPHY CATHETERS, 2021-2026 (IN $ MILLION)

FIGURE 29: UNITED STATES PERIPHERAL CATHETERS MARKET, BY GUIDING CATHETERS, 2021-2026 (IN $ MILLION)

FIGURE 30: UNITED STATES PERIPHERAL ARTERY DISEASE MARKET, BY PERIPHERAL ACCESSORIES, 2021-2026 (IN $ MILLION)

FIGURE 31: UNITED STATES PERIPHERAL ACCESSORIES MARKET, BY PERIPHERAL VASCULAR CLOSURE DEVICES, 2021-2026 (IN $ MILLION)

FIGURE 32: UNITED STATES PERIPHERAL ACCESSORIES MARKET, BY GUIDEWIRES, 2021-2026 (IN $ MILLION)

FIGURE 33: UNITED STATES PERIPHERAL ACCESSORIES MARKET, BY BALLOON INFLATION DEVICES, 2021-2026 (IN $ MILLION)

FIGURE 34: UNITED STATES PERIPHERAL ACCESSORIES MARKET, BY INTRODUCER SHEATHS, 2021-2026 (IN $ MILLION)

Request For A Free Sample